HOME >> BIOLOGY >> NEWS
JCI table of contents: August 1, 2007

EDITOR'S PICK: Developing a more effective vaccine for tuberculosis

The microorganism that causes tuberculosis, M. Tuberculosis, infects more than a one third of the world's population. Although the currently used vaccine (M. bovis BCG) provides young children with protection from tuberculosis, it is not effective at preventing the type of tuberculosis that most adolescents and adults suffer from. Therefore, there is an intensive research effort designed to develop new, more efficient vaccines that protect all individuals from tuberculosis.

In a study that appears in the August issue of the Journal of Clinical Investigation, Steven Porcelli and colleagues from the Albert Einstein College of Medicine, New York, show that in mice, immune cells known as CD8+ T cells are more efficiently activated by strains of M. Tuberculosis that lack a protein known as SecA2 than strains of M. Tuberculosis that express SecA2. Efficient CD8+ T cell activation was associated with increased death (by a process known as apoptosis) of another immune cell type, the macrophage. Importantly, vaccination of mice and guinea pigs with M. Tuberculosis lacking SecA2 provided increased protection against infection with M. Tuberculosis than did vaccination with M. bovis BCG. These data led the authors to suggest that this approach, in combination with others currently under development, could be used to generate a new vaccine that protects all individuals from tuberculosis.

The importance of this study for the development of new vaccines to control the tuberculosis pandemic is discussed in more detail in the accompanying commentary by W. Henry Boom from Case Western Reserve University.

TITLE: Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis

AUTHOR CONTACT:
Steven A. Porcelli
Albert Einstein College of Medicine, New York, New York, USA.
Phone: (718) 430-3228; Fax: (718) 430-8711
'"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
1-Aug-2007


Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. US Department of Defense awards $1.6 million for implantable biochip research
4. More fish oil, less vegetable oil, better for your health
5. JCI table of contents -- July 26, 2007
6. JCI table of contents: July 19, 2007
7. JCI table of contents: July 12, 2007
8. JCI table of contents: June 21, 2007
9. JCI table of contents: June 14, 2007
10. Food safety begins as vegetables grow
11. Turning the tables in chemistry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... GSL ... connect seamlessly with LabArchives , the leading cloud-based Electronic Lab Notebook (ELN) platform. ... LabArchives enables researchers to store all of their research data records in a secure, ...
(Date:7/28/2018)... ... 2018 , ... Inthirani Arul, an evidence-based healer, today announces research results based ... autoimmune disorders. , Biomarkers for immune function, blood, as well as, inflammation, were ... 110% increase in overall immunity as seen by the rise in antibody levels , ...
(Date:7/26/2018)... ... , ... The Conference Forum has confirmed the agenda for the 5th Annual ... the Marriott Copley Place in Boston, MA. , Daniel Karlin, MD, Head of Experimental ... to lead the discussion on how and when to implement mobile/digital technology in clinical ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... (PRWEB) , ... July 25, 2018 , ... ... a biofield energy treated proprietary nutraceutical to combat inflammation and autoimmune disorders. ... as, immune function response. The following data was reported:, ...
(Date:7/24/2018)... ... 2018 , ... Mark Stutheit, an evidence-based energy healer, today ... improve anti-inflammatory, and immune function responses. , Biomarkers for systemic and organ-specific inflammation, ... reduced. Results are as follows:, , More than 40% ...
(Date:7/22/2018)... ... July 19, 2018 , ... Mitotech S.A, ... Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Under the ... with approximately $17m allocated towards the first Phase 3 study starting as early ...
(Date:10/12/2017)... ... October 12, 2017 , ... They call it ... biological network, a depiction of a system of linkages and connections so complex ... associate professor of computer science at Worcester Polytechnic Institute (WPI) and director of ...
Breaking Biology Technology:
Cached News: